Xiaohan Qian

Xiaohan Qian

Auto-generated profile, based on publicly available information

Xiaohan Qian

Division of Gastroenterology and Hepatology Stanford University Medical Center Palo Alto California USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2020 in Biological Reviews
Verified
Journal Article
Closed access
PDF file
YYYuanfa Yao
Yuanfa Yao
XWXinyi Wang
Xinyi Wang
HLHanbing Li
Hanbing Li
JFJiannan Fan
Jiannan Fan
XQXiaohan Qian
Xiaohan Qian
YXYingke Xu
Yingke Xu

20 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XZXiaoxu Zhou
Xiaoxu Zhou
JWJian Wang
Jian Wang
JCJunye Chen
Junye Chen
YQYuankai Qi
Yuankai Qi
DNDi Nan
Di Nan
YXYingke Xu
Yingke Xu
Epithelial-mesenchymal transition (EMT) is one of the most important mechanisms in the initiation and promotion of cancer cell metastasis. The phosphoinositide 3-kinase (PI3K) signaling pathway has been demonstrated to be involved in TGF-β induced EMT, but the complicated TGF-β signaling network makes it challenging to dissect the important role of PI3K on regulation of EMT process. Here, we applied optogenetic controlled PI3K module (named ‘Opto-PI3K’), which based on CRY2 and the N-terminal of CIB1 (CIBN), to rapidly and reversibly control the endogenous PI3K activity in cancer cells with light. By precisely modulating the kinetics of PI3K activation, we found that E-cadherin is an important downstream target of PI3K signaling. Compared with TGF-β treatment, Opto-PI3K had more potent effect in down-regulation of E-cadherin expression, which was demonstrated to be regulated in a light dose-dependent manner. Surprisingly, sustained PI3K activation induced partial EMT state in A549 cells that is highly reversible. Furthermore, we demonstrated that Opto-PI3K only partially mimicked TGF-β effects on promotion of cell migration in vitro. These results reveal the importance of PI3K signaling in TGF-β induced EMT, suggesting other TGF-β regulated signaling pathways are necessary for the full and irreversible promotion of EMT in cancer cells. In addition, our study implicates the great promise of optogenetics in cancer research for mapping input-output relationships in oncogenic pathways.

1 November 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
XQXiaohan Qian
Xiaohan Qian
XZXiaoxu Zhou
Xiaoxu Zhou
PSPing Shentu
Ping Shentu
YYYuanfa Yao
Yuanfa Yao
DJDemin Jiao
Demin Jiao
YXYingke Xu
Yingke Xu

2 August 2025 in Thoracic Cancer
Verified
Journal Article
Open access
XQXiaohan Qian
Xiaohan Qian
MFMengjiao Fu
Mengjiao Fu
JZJing Zheng
Jing Zheng
JCJunjun Chen
Junjun Chen
CCCuihong Cai
Cuihong Cai
JZJianying Zhou
Jianying Zhou
Introduction: Previous studies have reported inconsistent findings regarding the associationbetween ALK and ROS1 rearrangements in lung cancer and thromboembolic risk. This retrospective study aimed to investigate this association in advanced lung adenocarcinoma patients with ALK, ROS1, RET rearrangements, and EGFR mutations.Materials and Methods: We retrospectively collected information on patients with advanced lung adenocarcinoma in the First Affiliated Hospital of Zhejiang University School of Medicine from January 2013 to March 2021. All patients with confirmed ALK, ROS1, or RET rearrangements, as well as a comparison cohort of those with EGFR mutation, were included. Clinical characteristics were analyzed, and the association between driver genes and TE risks was analyzed using competing risk and logistic regression.Results: A total of 546 patients were included in the study. Among them, those with ROS1 rearrangements exhibited the highest cumulative incidence of thromboembolic events (TEs), reaching 17.5% ± 0.2% during the peri‐diagnostic period (within 6 months following diagnosis). Regardless of the entire follow‐up or the peri‐diagnostic period, ROS1 rearrangements were significantly associated with an increased risk of TEs. Multivariate analysis revealed ROS1 rearrangements, the number of comorbidities, the size of mediastinal lymph nodes, and elevated C‐reactive protein (CRP) levels as TE risk factors during the peri‐diagnostic period. Throughout the follow‐up period, ROS1 rearrangements and hypertension were independent TE risk factors. In addition, the development of TE significantly affected the overall survival of patients with EGFR mutations.Conclusion: ROS1 rearrangements were significantly associated with an increased risk of TE.

14 October 2026 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
SKSahith Kudaravalli
Sahith Kudaravalli
TYTaotao Yan
Taotao Yan
CTCheng‐Hao Tseng
Cheng‐Hao Tseng
YHYao‐Chun Hsu
Yao‐Chun Hsu
XLXiaohe Li
Xiaohe Li
Mindie H. NguyenMindie H. Nguyen
Mindie H. Nguyen